Why your brain is primed for a high

Kleiner, Kurt
March 1999
New Scientist;03/27/99, Vol. 161 Issue 2179, p14
States that the function of brain receptors to which cannabinoid drugs bind is being uncovered. Details about the involvement of the chemical, called anandamide; Mention of the research of Daniele Piomelli et al; Possible benefit to Parkinson's patients.


Related Articles

  • Potential Role of Cannabinoids in Parkinson’s Disease. Ševcík, J.; Mašek, K. // Drugs & Aging;2000, Vol. 16 Issue 6, p391 

    Parkinson’s disease (PD) is a neurodegenerative disorder caused by a progressive loss of dopaminergic neurons of the substantia nigra, resulting from an oxidative stress. The lack of dopaminergic neurons is reflected by a disturbed balance of the neural circuitry in the basal ganglia....

  • Routine outpatient L-dopa monitoring in elderly patients with Parkinson's disease. Copeland, L.G.; Dutton, J. // Age & Ageing;Mar1994, Vol. 23 Issue 2, p138 

    Investigates the potential role of single-timed L-dopa measurements in the management of elderly patients with Parkinson's disease in the outpatient department. Examination of the compliance, dose-related side-effects and L-dopa dosage requirements; Details of patients and plasma L-dopa...

  • Controlled trial of physiotherapy and occupational therapy for Parkinson's disease. Gibberd, F.B.; Page, N.G.R.; Spencer, K.M.; Kinnear, E.; Hawksworth, J.B. // British Medical Journal (Clinical Research Edition);4/11/1981, Vol. 282 Issue 6271, p1196 

    Focuses on the controlled cross-over trial of physiotherapy and occupational therapy for patients with Parkinson's disease. Assessment of the gait and rigidity of the worst arm of the patients; Techniques used for active physiotherapy and inactive treatment; Use of Wilcoxon's rank paired test...

  • Marijuana researchers reach for pot of gold. Mandavilli, Apoorva // Nature Medicine;Oct2003, Vol. 9 Issue 10, p1227 

    Presents updates on studies on the therapeutic use and other physiological effects of marijuana. Number of active compounds in cannabis sativa; Description of cannabinoid receptors; Delivery technologies for cannabis; Study of cannabidiol the second biggest ingredient in cannabis and the least...

  • short-term medical use of cannabis increases risk of non-serious adverse effects. Esson, Lynne // Evidence Based Nursing;Jan2009, Vol. 12 Issue 1, p7 

    An abstract is presented of the article "Adverse Effects of Medical Cannabinoids: A Systematic Review" by T. Wang et al. which appeared in a 2008 issue of the "Canadian Medical Association Journal" along with a brief commentary on the abstract.

  • D3's New Study Reveals a Novel Approach to Targetting Obesity.  // Biomedical Market Newsletter;7/5/2011, p5 

    The article discusses a study which reveals a biological response to fat intake for targeting obesity. It states that the study, conducted by the Drug Discovery and Development (D3) unit of the Italian Institute of Technology and the University of California, Irvine, shows that endocannabinoid...

  • Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease. Deleu, D.; Northway, M.G.; Hanssens, Y.; Deleu, Dirk; Northway, Margaret G; Hanssens, Yolande // Clinical Pharmacokinetics;2002, Vol. 41 Issue 4, p261 

    Current research in Parkinson's disease (PD) focuses on symptomatic therapy and neuroprotective interventions. Drugs that have been used for symptomatic therapy are levodopa, usually combined with a peripheral decarboxylase inhibitor, synthetic dopamine receptor agonists, centrally-acting...

  • Another possible benefit of hormone replacement therapy: It may slow Parkinson's. Saunders-Pullman, Rachel J. // Modern Medicine;Jun98, Vol. 66 Issue 6, p57 

    Discusses the therapeutic use of hormone replacement therapy in slowing Parkinson's disease. Other uses of hormone replacement therapy; Explanation on the significance of the therapy to the disease.

  • Medical Marijuana: Is the Cart Before the Horse? D'Souza, Deepak Cyril; Ranganathan, Mohini // JAMA: Journal of the American Medical Association;6/23/2015, Vol. 313 Issue 24, p2431 

    The article discusses papers published within the issue, including studies by P. F. Whiting et al. and K. P. Hill et al. on the pharmacology, indications, benefits, adverse effects and laws related to medical marijuana and the cannabinoids.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics